Day 1 - Friday, July 17 2015
Meeting category
Date(s)
17 Jul 2015 - 18 Jul 2015
Location
Vancouver,
Canada
Organizer
International Workshop on HIV & Pediatrics 2015
Related Enduring Materials
Enduring Materials
Session 1: Management of Pediatric HIV -
Pediatric Treatment Cascade: What Do We Need to Reach “90‐90‐90” for Children
TDF Use Across the Age Spectrum: From Fetus to Adolescent
Debate: CD4 Assays Are No Longer Needed for Care of Children in Lowresource Countries
CON ‐ standpoint : Diana Gibb, MD, MRCP, MSc
MRC Clinical Trials Unit, UK
Session 2: Abstract driven presentations -
Abstract driven presentations
Virologic Outcomes of Children Switched from Lopinavir/Ritonavir‐ to Efavirenz‐Based Antiretroviral Treatment: a retrospective cohort study
Kirsten Reichmuth
The effect of systemic exposure to efavirenz, sex and age on the risk of virological non‐suppression in HIV‐infected African children.
Andrzej Bienczak
Lopinavir ritonavir (1:1 ratio) in the presence of rifampicin is not inferior to lopinavir ritonavir (4:1 ratio) in the absence of rifampicin in Human Immune Deficiency Virus (HIV) children. Interim analysis of an open label sequential non‐randomized phar
Cotton Mark
Durability of first‐line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC)
Ruth Goodall
Efavirenz‐based therapy may simplify antiretroviral LPV‐based therapy initiated in HIV‐1‐infected children before the age of 2 in West‐Africa: the MONOD trial ANRS 12206.
Valeriane Leroy
Poster viewing session 1
Session 3: Adolescents -
Innovative Adherence Interventions for HIV‐Infected Youth
Session 4: Abstract driven presentations -
Abstract driven presentations
Anxiety and depression in young people with perinatal HIV and their HIVnegative siblings
Marthe Le Prevost
Hepatitis B Treatment Response to TDF in 3TC‐experienced Perinatally HIVinfected Adolescents
Linda Aurpibul
Prevalence and Associated Factors of Nonalcoholic Fatty Liver Disease and Liver Fibrosis among Perinatally HIV‐infected Asian Adolescents
Tavitiya Sudjaritruk
Week 48 safety and efficacy of a rilpivirine (TMC278)‐based regimen in HIVinfected treatment‐naïve adolescents: PAINT Phase II trial
Patricia Flynn
Session 5: Peer Support to Promote Transition – Voices of Youth -
Jason noted youth Camp in Canada near Vancouver at same time as meeting – suggested we might have time for youth to talk about the camp and how it affected their lives? Jason, could this be a 30 presentation – would need to be carefully orchestrated and p
youth participants to the camp
-
Day 2 - Saturday, July 18 2015
Session 6: Emerging issues in PMTCT -
Mark Cotton, MD, PhD
Young Investigator Award
Second‐line ART treatment and resistance outcomes of Asian children
Round Table Discussion: HIV testing at birth: potential benefits, risks and feasibility
Overview lecture on Pros and Cons
Panel Discussion
Tygerberg Children’s Hospital (TCH), Stellenbosch University (SU), South Africa
Rangsima Lolekha
CDC, Bangkok, Thailand
Appolinaire Tiam
EPGAF, Lesotho, South Africa
Debate: HIV‐Exposed Uninfected Infants Require Lifelong Follow Up in All
Session 7: Emerging issues in PMTCT ‐ Abstract Driven Presentations -
Abstract Driven Presentations
HIV exposed uninfected South African infants experience greater severity but not frequency of common infectious diseases than HIV unexposed uninfected infants
Amy Slogrove
Perturbations in gut microbiome in HIV‐exposed uninfected (HEU) infants are related to maternal microbiome and human milk oligosaccharides
Louise Kuhn
The impact of adding a virological testing at birth to the existing WHO infant testing algorithm in the 21 Global Plan countries.
Martina Penazzato
Effectiveness of conditional cash transfers to increase retention in care and adherence to PMTCT services: A randomized controlled trial
Marcel Yotebieng
In utero Tenofovir Exposure is Not Associated with Poor Fetal Long Bone Growth
Jennifer Jao
Psychosocial factors in younger versus older HIV‐infected pregnant women initiating antiretroviral therapy in Cape Town, South Africa
Marcia Wong
Poster Viewing session 2
Session 8: Coinfections and Complications -
Hepatitis C virus Infection in Children with and without HIV ‐ Epidemiologynsmission (MTCT) of HIV during Breastfeeding (BF)
Lower immune response in HIV‐positive girls to the quadrivalent human papillomavirus vaccine
Session 9: Abstract Driven Presentations continued -
Abstract Driven Presentations
Changes in renal laboratory parameters and bone mineral density in treatment‐naïve HIV‐1‐infected adolescents initiating E/C/F/TAF or E/C/F/TDF
Sean Bennett
Decreased bone mass in perinatally HIV‐infected school‐aged South African children on antiretrovirals
Stephanie Shiau
Early cardio‐pulmonary disease in children despite early ART ‐ Evidence from CHER cohort
Steve Innes
Computerized cognitive rehabilitation training can improve neuropsychological outcomes in rural school‐age Ugandan children with HIV.
Michael Boivin
Overview
Welcome
The 7th International Workshop on HIV Pediatrics was held on 17 - 18 July 2015 in the Fairmont Waterfront Hotel in Vancouver, Canada.
The Organizing Committee would like to thank all invited speakers and participants for their contribution to this workshop.
We would like to thank our sponsors ViiV Healthcare, Gilead, Janssen, Mylan, PENTA and Unicef for making this event possible.
Support
Gold Level
Silver Level
Principal Supporter
Support
Affiliated independent event of:
Endorsers
Language
Related Programs
